Urine THC metabolite levels moderately predicted cannabis withdrawal severity during detox | Research

The takeaway

In 78 cannabis-dependent adults undergoing inpatient detoxification, urine THC metabolite levels significantly predicted withdrawal severity with a moderate correlation, and females showed prolonged elimination and withdrawal.

Addiction medicine clinicians, cannabis withdrawal researchers

Urine THC-COOH levels predicted withdrawal severity (r = 0.248); females had prolonged elimination

What the researchers found

Urinary THC-COOH levels significantly correlated with Marijuana Withdrawal Checklist scores across the 24-day study (r = 0.248, p < 0.001). Day-to-day changes in THC-COOH also predicted withdrawal severity. MWC scores correlated strongly with Clinical Global Impression severity (r = 0.812). Females showed prolonged THC-COOH elimination and cannabis withdrawal.

Why it matters

A simple urine test that can predict withdrawal severity could help clinicians plan treatment duration and intensity for cannabis detoxification.

The numbers in context

78 subjects; 24-day inpatient detox; 13 measurement days. THC-COOH and MWC correlation: r = 0.248. MWC and CGI-S correlation: r = 0.812. Females showed prolonged elimination and withdrawal.

How the study worked

Observational study of 78 adult chronic cannabis-dependent subjects over 24-day inpatient detoxification with 13 serial measurement days. Point-of-care enzyme immunoassay measured urinary THC-COOH. Repeated measures correlation and multilevel linear models used.

What this study cannot tell us

Moderate correlation means the test is informative but not highly precise; single-center study; POC immunoassay is less accurate than mass spectrometry; sex difference finding needs replication given small female subsample.

How to read the evidence

Moderate-sized observational study with serial measurements and appropriate statistical methods.

When this study was published

Published in 2020.

The bigger picture

Cannabis withdrawal is increasingly recognized as clinically significant. Having a biological marker to guide treatment planning could improve detoxification outcomes.

Questions still open

Could combining urine levels with clinical measures improve prediction accuracy? What biological factors explain the sex difference in elimination?

Common questions

Can a urine test predict how bad cannabis withdrawal will be?

This study found a moderate but significant correlation between urine THC metabolite levels and withdrawal severity. The test is informative but not precise enough to be the sole predictor of withdrawal outcomes.

Why did women have longer withdrawal?

The study found females had prolonged THC-COOH elimination and cannabis withdrawal, possibly because THC is stored in fat tissue and body composition differences between sexes may affect elimination kinetics. More research is needed to confirm this finding.

Read the original research

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Frontiers in psychiatry, 11, 598150

View on PubMed ↗Publisher’s paper ↗

Citation

Claus, Benedikt Bernd; Specka, Michael; McAnally, Heath; Scherbaum, Norbert; Schifano, Fabrizio; Bonnet, Udo. (2020). Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?. Frontiers in psychiatry, 11, 598150. https://doi.org/10.3389/fpsyt.2020.598150